Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796131 | 12579613 | 1 | I | 20120304 | 20130919 | 20160721 | 20160721 | EXP | CA-FRI-1000059688 | FOREST | 62.00 | YR | F | Y | 46.00000 | KG | 20160721 | OT | FR | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125796131 | 12579613 | 1 | PS | SAPHRIS | ASENAPINE MALEATE | 1 | Sublingual | 10 MG | Y | 22117 | 5 | MG | TABLET | BID | |||||
| 125796131 | 12579613 | 2 | SS | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | Oral | 250 MG | U | 0 | 250 | MG | QD | ||||||
| 125796131 | 12579613 | 3 | SS | DIVALPROEX SODIUM. | DIVALPROEX SODIUM | 1 | Oral | 250 MG | U | 0 | |||||||||
| 125796131 | 12579613 | 4 | SS | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 200 MG | Y | 0 | TABLET | ||||||||
| 125796131 | 12579613 | 5 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 150 MG | Y | 0 | PROLONGED-RELEASE TABLET | ||||||||
| 125796131 | 12579613 | 6 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 150 MG | Y | 0 | |||||||||
| 125796131 | 12579613 | 7 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 150 MG | Y | 0 | |||||||||
| 125796131 | 12579613 | 8 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG | 0 | CREAM | |||||||||
| 125796131 | 12579613 | 9 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | Oral | 5 MG | 0 | TABLET | |||||||||
| 125796131 | 12579613 | 10 | C | CETIRIZINE | CETIRIZINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 125796131 | 12579613 | 11 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | 1 MG | 0 | TABLET | |||||||||
| 125796131 | 12579613 | 12 | C | HYDROCORTISONE ACETATE. | HYDROCORTISONE ACETATE | 1 | Topical | 0 | CREAM | ||||||||||
| 125796131 | 12579613 | 13 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | 0 | TABLET | |||||||||||
| 125796131 | 12579613 | 14 | C | LORAZEPAM. | LORAZEPAM | 1 | 0 | ||||||||||||
| 125796131 | 12579613 | 15 | C | OLANZAPINE. | OLANZAPINE | 1 | 0 | CREAM | |||||||||||
| 125796131 | 12579613 | 16 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | Topical | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125796131 | 12579613 | 1 | Bipolar disorder |
| 125796131 | 12579613 | 2 | Bipolar disorder |
| 125796131 | 12579613 | 4 | Bipolar disorder |
| 125796131 | 12579613 | 5 | Bipolar disorder |
| 125796131 | 12579613 | 9 | Rash |
| 125796131 | 12579613 | 10 | Pruritus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125796131 | 12579613 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125796131 | 12579613 | Contusion | |
| 125796131 | 12579613 | Glossodynia | |
| 125796131 | 12579613 | Oropharyngeal pain | |
| 125796131 | 12579613 | Pruritus | |
| 125796131 | 12579613 | Rash | |
| 125796131 | 12579613 | Swelling |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125796131 | 12579613 | 1 | 20120304 | 20120324 | 0 | |
| 125796131 | 12579613 | 2 | 2010 | 0 | ||
| 125796131 | 12579613 | 3 | 2010 | 0 | ||
| 125796131 | 12579613 | 4 | 2010 | 20120328 | 0 | |
| 125796131 | 12579613 | 5 | 20120328 | 0 | ||
| 125796131 | 12579613 | 6 | 20120328 | 0 | ||
| 125796131 | 12579613 | 7 | 20120328 | 0 |